Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?

被引：0
作者：
Antoine Italiano
机构：
[1] Institut Bergonié,Department of Medical Oncology
[2] University of Bordeaux,undefined
[3] Institut Bergonié,undefined
来源：
Current Treatment Options in Oncology | 2018年 / 19卷
关键词：
Sarcoma; Next-generation sequencing; Targeted therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Soft-tissue sarcomas represent a heterogeneous group of diseases accounting for up to 1% of cancer in adults and 15% of cancer in children. Introduction of next-generation sequencing (NGS) technologies has allowed to gain additional insight into the genetic diversity and complexity of sarcomas, including the potential therapeutic implications of some genetic alterations.
引用
收藏
相关论文
共 10 条
  • [1] O’Leary M(2008)Progress in childhood cancer: 50 years of research collaboration, a report from the Children’s Oncology Group Semin Oncol 35 484-493
  • [2] Krailo M(2002)Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 2002 472-480
  • [3] Anderson JR(2005)Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study B2225 J Clin Oncol 23 866-873
  • [4] Reaman GH(undefined)undefined undefined undefined undefined-undefined
  • [5] Demetri GD(undefined)undefined undefined undefined undefined-undefined
  • [6] von Mehren M(undefined)undefined undefined undefined undefined-undefined
  • [7] Blanke CD(undefined)undefined undefined undefined undefined-undefined
  • [8] McArthur GA(undefined)undefined undefined undefined undefined-undefined
  • [9] Demetri GD(undefined)undefined undefined undefined undefined-undefined
  • [10] van Oosterom A(undefined)undefined undefined undefined undefined-undefined
1